Published on
July 17, 2024
- 16:00 GMT
Next-Generation Midi-Dystrophin Gene Therapy Strategy Reported in Nature
Breakthrough gene replacement strategy for patients with Duchenne muscular dystrophy reported in Nature using gene-splicing technology to create midi-dystrophin SEATTLE, WASHINGTON, USA, July 17, 2024 /EINPresswire.com/ -- Kinea Bio, Inc., a patient- …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
